European Archives - Page 810 of 1216 - European Medical Journal

The European Medical Journal Presents: EMJ 4.3

Our flagship journal has seen its third edition for 2019 published. European Medical Journal 4.3 contains a collection of thought-provoking, peer-reviewed…

European Medical Journal 4.3 2019

In this edition of EMJ 4.3, you will find a selection of peer-reviewed articles covering the latest developments across therapeutic areas including repro…

Variability of Biologics and its Impact on Biosimilar Development

Biologic drugs are transforming treatment of other hard-to-treat diseases beyond cancer, including multiple sclerosis, heart disease, asthma, and…

Moderate Psoriatic Arthritis and Perspectives from Phosphodiesterase-4 Inhibition

Dr Queiro-Silva opened the session by proposing a definition of the moderate-severity PsA patient: patients associated with a limited number of affected…

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Achieving and Sustaining Remission while Reducing Organ Damage

The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are a group of rare inflammatory diseases including microscopic polyangiitis…

Editor’s Pick: Systemic Sclerosis: The Role of YAP/TAZ in Disease Pathogenesis

Systemic sclerosis (SSc) is a multi-system connective tissue disease characterised by excessive fibrosis, microvasculopathy, and autoimmunity…

Noninvasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?

New imaging modalities are emerging and may potentially replace biopsy. This review discusses the different noninvasive imaging modalities…

Scalp Sarcoidosis with Systemic Involvement: A Case Report and Literature Review

Sarcoidosis is a multisystem disease, of unknown aetiology, which can involve any organ of the body, even if it more frequently affects the lymph nodes…

A Versatile, Low-Cost, Three-Dimensional-Printed Ultrasound Procedural Training Phantom of the Human Knee

The use of ultrasonography has been increasing across many specialties, including rheumatology…

Cholestasis in the Baby and Infant

Cholestasis is seen in every 2,500–5,000 live births. In full-term infants, jaundice that lasts >2 weeks should be evaluated; however, it should be…